Moolec Science (MLEC) Short term Debt (2022 - 2025)
Moolec Science's (MLEC) quarterly Short term Debt came in at $227.2 million in Q2 2025, down 3.14% year-on-year from $234.5 million in Q2 2024, and up 1072.59% quarter-over-quarter from $19.4 million in Q4 2024.
Moolec Science (MLEC) Short term Debt (2022 - 2025) Analysis & Trends
Moolec Science has disclosed Short term Debt across 4 years of filings, most recently posting $227.2 million for Q2 2025.
- Short term Debt for Q2 2025 came in at $227.2 million, down 3.14% year-over-year; the trailing twelve-month figure through Jun 2025 was $227.2 million (down 3.14% YoY), and the FY2025 annual result was $227.2 million, down 3.14% from the prior year.
- Short term Debt came in at $227.2 million for Q2 2025 at Moolec Science, up from $19.4 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $234.5 million in Q2 2024 to a low of $1.7 million in Q4 2022.
- The 4-year median for Short term Debt is $12.0 million (2023), against an average of $59.1 million.
- Across the five-year window, Short term Debt jumped 1856.56% in 2024 and slipped 3.14% in 2025, its largest moves.
- Moolec Science's Short term Debt stood at $1.7 million in 2022, then surged by 237.11% to $5.6 million in 2023, then soared by 244.83% to $19.4 million in 2024, then surged by 1072.59% to $227.2 million in 2025.
- The last three Short term Debt figures came in at $227.2 million (Q2 2025), $19.4 million (Q4 2024), and $18.2 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 227.15 Mn |
| Dec 31, 2024 | 19.37 Mn |
| Sep 30, 2024 | 18.22 Mn |
| Jun 30, 2024 | 234.51 Mn |
| Mar 31, 2024 | 10.61 Mn |
| Dec 31, 2023 | 5.62 Mn |
| Sep 30, 2023 | 2.39 Mn |
| Jun 30, 2023 | 11.99 Mn |
| Dec 31, 2022 | 1.67 Mn |